Anthem INC (ANTM) Shareholder Loews Corp Decreased Its Stake as Shares Declined

June 29, 2018 - By Michael Lund

Anthem, Inc. (NYSE:ANTM) Corporate Logo

Loews Corp’s holdings in Anthem Inc (ANTM) is decreased by 85.96% based on its latest 2018Q1 regulatory filing with the SEC. The company’s stock sank 2.45% while Loews Corp sold 14,700 shares. The institutional investor is holding 2,400 shares, compared to the 17,100 from the previous quarter. And the reported value of the health care company is $527,000 for the 2018Q1. Anthem Inc has $61.54 billion market cap. ANTM hit $241.15 during the last trading session after $1.88 change.Anthem, Inc. has volume of 349,333 shares. Since June 29, 2017 ANTM has risen 28.04% and is uptrending. The stock outperformed the S&P500 by 15.47%.

About $14.93B US Long portfolio Loews Corp manages. According to a filing the fund rose its stake in Aetna Inc (NYSE:AET) by 34,000 shares to 189,600 shares, valued at $32.04 million in 2018Q1. Loews Corp has risen its stake in General Motors Co. (NYSE:GM) and also increased its holding in Barrick Gold Corp (NYSE:ABX) by 700,000 shares in the quarter, for a total of 918,005 shares.

On July, 25 is expected Anthem, Inc. (NYSE:ANTM)’s earnings report, according to Faxor. The earnings per share diference is $0.79 or 23.44 % up from last years number. Previous year: $3.37; Analysts forcast: $4.16. ANTM’s profit could be $1.06 billion with 14.49 P/E in case $4.16 earnings per share is published. -23.11 % negative EPS growth is what analysts predict. $5.41 earnings per share was published for previous quarter.

For more Anthem, Inc. (NYSE:ANTM) news announced briefly go to:,,, or The titles are as follows: “6 Top Healthcare Trends You Can’t Afford to Ignore” announced on June 27, 2018, “Castlight Health Has $10B Potential Market, William Blair Says In Bullish Initiation” on June 20, 2018, “Blue Cross of MN names Anthem exec CEO” with a publish date: June 28, 2018, “Market Trends Toward New Normal in Cheniere Energy Partners, LP, UnitedHealth Group, Anthem, Sage Therapeutics …” and the last “Anthem, Inc. Completes Acquisition of Aspire Health” with publication date: June 18, 2018.

Anthem, Inc. (NYSE:ANTM) Ratings Coverage

In total 15 analysts cover Anthem (NYSE:ANTM). “Buy” rating has 13, “Sell” are 0, while 2 are “Hold”. 87% are bullish. 20 are the (NYSE:ANTM)’s analyst reports since January 3, 2018 according to StockzIntelligence Inc. The stock rating was maintained by Bernstein with “Buy” on Thursday, April 26. On Thursday, April 26 the rating was upgraded by J.P. Morgan to “Buy”. In Thursday, January 18 report Cantor Fitzgerald maintained the stock with “Buy” rating. The company rating was maintained by Leerink Swann on Friday, March 9. On Wednesday, January 31 the rating was maintained by Jefferies with “Buy”. On Thursday, February 1 the rating was maintained by Wells Fargo with “Outperform”. On Wednesday, January 31 the rating was maintained by Cowen & Co with “Buy”. On Wednesday, April 25 the firm has “Buy” rating by Cantor Fitzgerald given. In Thursday, April 26 report Credit Suisse maintained it with “Outperform” rating and $284 target. On Thursday, February 1 the rating was maintained by Morgan Stanley with “Equal-Weight”.

Anthem, Inc. (NYSE:ANTM) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: